Brandon Joel Zipp - 10 Dec 2021 Form 4 Insider Report for MALACHITE INNOVATIONS, INC. (RNGE)

Role
Chief Science Officer
Signature
/s/ Brandon Zipp
Issuer symbol
RNGE
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
13 Dec 2021, 08:00:17 UTC
Next filing
31 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -2,500 -100% $0.000000* 0 10 Dec 2021 Common Stock 2,500 $4.20 Direct F1, F7
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -7,500 -100% $0.000000* 0 10 Dec 2021 Common Stock 7,500 $4.40 Direct F2, F7
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -15,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 15,000 $4.20 Direct F3, F7
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -20,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 20,000 $3.40 Direct F4, F7
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -20,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 20,000 $2.10 Direct F5, F7
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -75,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 75,000 $1.81 Direct F6, F7
transaction MLCT Stock Option (Right to Buy) Award $0 +127,487 $0.000000 127,487 10 Dec 2021 Common Stock 127,487 $0.2770 Direct F7
transaction MLCT Stock Option (Right to Buy) Award $0 +22,513 +18% $0.000000 150,000 10 Dec 2021 Common Stock 22,513 $0.2770 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase 2,500 shares of common stock was granted to the Reporting Person on 3/11/13, 884 shares vested on 3/11/14, and 883 shares vested on each of 3/11/15 and 3/11/16.
F2 The option provided for vesting in three equal annual installments beginning on 3/12/13.
F3 The option provided for vesting in eight equal quarterly annual installments beginning on 7/3/14.
F4 The option provided for vesting in four equal semi-annual installments beginning on 7/1/15.
F5 The option provided for vesting in four equal semi-annual installments beginning on 11/21/15.
F6 The option provided for vesting in four equal semi-annual installments beginning on 6/27/18.
F7 On December 10, 2021, the issuer canceled this option, pursuant to the issuer's option exchange program, the options listed above. In exchange, the Reporting Person received a replacement option to purchase 127,487 shares at an exercise price of $0.277. This replacement option vested immediately.
F8 On December 10, 2021, the Reporting Person was granted options to purchase 22,513 shares of common stock at an exercise price of $0.277. This option vested immediately.